Detalles de la búsqueda
1.
Mac-2-Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
Dig Dis;
42(2): 166-177, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38219719
2.
Myosteatosis, but not Sarcopenia, Predisposes NAFLD Subjects to Early Steatohepatitis and Fibrosis Progression.
Clin Gastroenterol Hepatol;
21(2): 388-397.e10, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35101634
3.
(Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis.
FASEB J;
36(10): e22526, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36063123
4.
Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease.
Liver Int;
41(3): 494-504, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33164304
5.
Obeticholic acid ameliorates hepatorenal syndrome in ascitic cirrhotic rats by down-regulating the renal 8-iso-PGF2α-activated COX-TXA2 pathway.
Clin Sci (Lond);
134(15): 2055-2073, 2020 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725149
6.
Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease.
Lab Invest;
99(8): 1203-1216, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30918325
7.
Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Am J Pathol;
188(7): 1608-1624, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29929914
8.
Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
Dig Dis Sci;
64(1): 102-112, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30288660
9.
Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats.
Am J Physiol Endocrinol Metab;
314(5): E433-E447, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29118012
10.
Serum adrenomedullin and urinary thromboxane B2 help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort study.
Hepatol Res;
48(3): E9-E21, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544540
11.
Mechanisms of the prevention and inhibition of the progression and development of non-alcoholic steatohepatitis by genetic and pharmacological decoy receptor 3 supplementation.
Hepatol Res;
47(12): 1260-1271, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28066964
12.
Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding.
J Gastroenterol Hepatol;
32(11): 1859-1866, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28271564
13.
Metallic Stent Expansion Rate at Day One Predicts Stent Patency in Patients with Gastric Outlet Obstruction.
Dig Dis Sci;
62(5): 1286-1294, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28315029
14.
Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosis.
Hepatol Res;
45(3): 294-304, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24826996
15.
Concomitant inhibition of oxidative stress and angiogenesis by chronic hydrogen-rich saline and N-acetylcysteine treatments improves systemic, splanchnic and hepatic hemodynamics of cirrhotic rats.
Hepatol Res;
45(5): 578-88, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961937
16.
Comparative portal hypotensive effects as propranolol of vitamin D3 treatment by decreasing intrahepatic resistance in cirrhotic rats.
J Gastroenterol Hepatol;
30(3): 628-37, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25187428
17.
Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites.
J Hepatol;
61(5): 1004-13, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24953022
18.
Involvement of the HIF-1α and Wnt/ß-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.
Clin Sci (Lond);
126(2): 163-74, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23875703
19.
Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat.
Liver Int;
34(4): 521-34, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23998651
20.
Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats.
J Gastroenterol Hepatol;
29(5): 1073-82, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24325631